Search by Drug Name or NDC

    NDC 00143-9510-01 Etoposide 20 mg/mL Details

    Etoposide 20 mg/mL

    Etoposide is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is ETOPOSIDE.

    Product Information

    NDC 00143-9510
    Product ID 0143-9510_15cf77cf-4207-463d-b6ef-16163db5afb9
    Associated GPIs 21500010002025
    GCN Sequence Number 008841
    GCN Sequence Number Description etoposide VIAL 20 MG/ML INTRAVEN
    HIC3 V1F
    HIC3 Description ANTINEOPLASTICS,MISCELLANEOUS
    GCN 07481
    HICL Sequence Number 003930
    HICL Sequence Number Description ETOPOSIDE
    Brand/Generic Generic
    Proprietary Name Etoposide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Etoposide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 20
    Active Ingredient Units mg/mL
    Substance Name ETOPOSIDE
    Labeler Name Hikma Pharmaceuticals USA Inc.
    Pharmaceutical Class Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA074290
    Listing Certified Through 2024-12-31

    Package

    NDC 00143-9510-01 (00143951001)

    NDC Package Code 0143-9510-01
    Billing NDC 00143951001
    Package 1 VIAL in 1 BOX, UNIT-DOSE (0143-9510-01) / 5 mL in 1 VIAL
    Marketing Start Date 2017-10-23
    NDC Exclude Flag N
    Pricing Information N/A